Ventilator Induced Lung Injury Clinical Trial
Official title:
Determination of Ventilatory Parameters and Inflammatory Responses of Neonates Who Are Ventilated by Volume Guarantee Combined With Synchronized Intermittent Mandatory Ventilation or Pressure Support Ventilation
Verified date | November 2013 |
Source | Gazi University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Turkey: Ethics Committee |
Study type | Interventional |
The main purpose of this study is to investigate effects of SIMV+VG (synchronized intermittent mandatory ventilation+volume guarantee) or PSV+VG (pressure support ventilation+volume guarantee) ventilation on vital signs, patient - mechanical ventilation synchrony, ventilation parameters and inflammatory mediators in neonates.
Status | Completed |
Enrollment | 40 |
Est. completion date | November 2013 |
Est. primary completion date | November 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 24 Hours |
Eligibility |
Inclusion Criteria: - neonates with respiratory distress who need mechanical ventilation - gestational age less than or equal to 37 weeks - neonates who need mechanical ventilation within first 24 hours Exclusion Criteria: - neonates who need mechanical ventilation other than conventional ventilation |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Turkey | Gazi University Hospital, Department of Pediatrics, Division of Newborn Medicine | Besevler | Ankara |
Lead Sponsor | Collaborator |
---|---|
Gazi University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | IL-1beta levels in tracheal aspirate material | Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported | Baseline and 72 hours of mechanical ventilation | No |
Primary | IL-6 level in tracheal aspirate | Tracheal aspirate will be analyzed for IL6 level and the change from baseline will be reported | Baseline and 72 hours of mechanical ventilation | No |
Primary | IL-8 in tracheal aspirate material | Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported | Baseline and 72 hours of mechanical ventilation | No |
Primary | IL-10 level in tracheal aspirate material | Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported | Baseline and 72 hours of mechanical ventilation | No |
Primary | TNF alfa in tracheal aspirate material | Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported | Baseline and 72 hours of mechanical ventilation | No |
Primary | tidal volume variability | variability in tidal volume measured with babyview program | 72 hours of mechanical ventilation or entire ventilation time if extubated earlier | Yes |
Primary | peak inspiratory pressure variability | variability in peak inspiratory pressure measured with babyview program | 72 hours of mechanical ventilation or entire ventilation time if extubated earlier | Yes |
Primary | respiratory rate variability | changes in respiratory rate, tacypnea rate | 72 hours of mechanical ventilation or entire ventilation time if extubated earlier | Yes |
Primary | oxygen saturation variability | changes in oxygen saturation, desaturation rate, hyperoxy rate | 72 hours of mechanical ventilation or entire ventilation time if extubated earlier | Yes |
Primary | lowest carbondioxide level (mmHg) | ratio of hypocarbic blood gases and least pCo2 level | 72 hours of mechanical ventilation or entire ventilation time if extubated earlier | Yes |
Primary | highest carbondioxide level (mmHg) | ratio of hypercarbic blood gases and highest pCo2 level | 72 hours of mechanical ventilation or entire ventilation time if extubated earlier | Yes |
Primary | lowest oxygen level (mmHg) | ratio of hypoxic blood gases and least pO2 level | 72 hours of mechanical ventilation or entire ventilation time if extubated earlier | Yes |
Primary | highest oxygen level (mmHg) | ratio of hyperoxic blood gases and highest pO2 level | 72 hours of mechanical ventilation or entire ventilation time if extubated earlier | Yes |
Secondary | bronchopulmonary dysplasia | Oxygen requirement at 36 weeks corrected age | 36 weeks corrected age | Yes |
Secondary | patent ductus arteriosus | Presence of hemodynamically significant patent ductus arteriosus in the first 7 days of life | in the first week of post natal life of the patient | No |
Secondary | necrotizing enterocolitis | Necrotising entercolitis defined by clinical and radiological findings | 36 weeks corrected age | No |
Secondary | intraventricular hemorrhage | Intraventricular hemorrhage diagnosed by head ultrasound | during first week | Yes |
Secondary | pneumothorax | Air leak diagnosed by chest x-ray | during first 3 days | Yes |
Secondary | pulmonary interstitial emphysema | Air leak diagnosed by x-ray | during first week | Yes |
Secondary | pulmonary hemorrhage | during first week | Yes | |
Secondary | retinopathy of prematurity | Retinal disease diagnosed by indirect opthtalmoscopic exam | until 36 weeks corrected age | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02670460 -
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing, a First in Human Trial
|
N/A | |
Recruiting |
NCT01502332 -
Intensive Alveolar Recruitment Protocol After Cardiac Surgery
|
N/A | |
Active, not recruiting |
NCT01959009 -
High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Blood Oxygenation and Stability of Oxygenation
|
N/A |